Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.

Rohit Saxena, Swati Phuljhele, Anupam Prakash, Rakesh Lodha, Digvijay Singh, Satya Karna, Anant Mohan, Rashmin Gandhi, Vimla Menon, Rajiv Garg, The Inosrg

The Journal of the Association of Physicians of India 2021 Feb

filter terms:

There has been change in the guidelines for the management of tuberculosis in India. The new guidelines advocate the daily use of Ethambutol for both intensive and continuation phase of the treatment. This may be a matter of concern as increased cumulative dose may lead to increase in incidence of toxic optic neuropathy due to ethambutol. Indian Neuro-Ophthalmology Society has taken cognizance of the issue and has come-up with guidelines for prevention and early detection of the toxic optic neuropathy. © Journal of the Association of Physicians of India 2011.

Citation

Rohit Saxena, Swati Phuljhele, Anupam Prakash, Rakesh Lodha, Digvijay Singh, Satya Karna, Anant Mohan, Rashmin Gandhi, Vimla Menon, Rajiv Garg, The Inosrg. Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen. The Journal of the Association of Physicians of India. 2021 Feb;69(2):54-57